12/22/2025
In this podcast, listen to Sean Kelly, MD, of The Ohio State University and The Ohio State University Wexner Medical Center, review the current nomenclature and risk factors associated with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction Associated Steatohepatitis (MASH). He will describe recommended screening and evaluation approaches and evidence-based therapies for management of metabolic liver disease. -> https://bit.ly/3XWdYq8
Case Western Reserve University School of Medicine
University of Cincinnati College of Medicine
Northeast Ohio Medical University
Ohio University Heritage College of Osteopathic Medicine
Ohio State University College of Medicine
The University of Toledo College of Medicine and Life Sciences
Wright State University Boonshoft School of Medicine